Published in J Clin Oncol on May 01, 1994
Routine follow up of breast cancer in primary care: randomised trial. BMJ (1996) 5.91
Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ (1997) 2.93
It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol (1994) 0.76
Cost-effective follow-up of breast cancer patients. J Clin Oncol (1994) 0.75
"Salvage" therapy? J Clin Oncol (1994) 0.75
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Methodologic lessons learned from hot flash studies. J Clin Oncol (2001) 2.82
Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol (1998) 2.24
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol (1990) 1.74
Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther (2011) 1.62
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol (2000) 1.43
Soy for breast cancer survivors: a critical review of the literature. J Nutr (2001) 1.43
An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care (2001) 1.40
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol (1991) 1.33
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol (1994) 1.33
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol (1998) 1.29
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat (1999) 1.27
Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys (1996) 1.16
Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage (1998) 1.15
Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA (1995) 1.15
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol (2001) 1.12
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol (1999) 1.08
Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol (1994) 1.07
Induction of adrenal suppression by megestrol acetate. Ann Intern Med (1996) 1.07
Megestrol acetate-induced adrenal suppression. J Clin Oncol (1996) 1.06
DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer (1991) 1.05
Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer (1996) 1.03
Follow-up testing for curatively treated cancer survivors. What to do? JAMA (1995) 0.99
A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer (1990) 0.97
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer (1998) 0.96
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol (1997) 0.96
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol (1995) 0.95
A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer (1995) 0.94
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol (1996) 0.91
A qualitative approach to defining "hot flashes" in men. Urol Nurs (1994) 0.89
Use of orally administered opioids for cancer-related pain. Mayo Clin Proc (1994) 0.88
Regular use of a verbal pain scale improves the understanding of oncology inpatient pain intensity. J Clin Oncol (1994) 0.87
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer (1997) 0.87
Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate. J Clin Oncol (1999) 0.87
A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer (1997) 0.86
Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol (1984) 0.86
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. J Clin Oncol (1986) 0.85
Sex differences in fluorouracil-induced stomatitis. J Clin Oncol (2000) 0.84
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer (1999) 0.84
Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Clin Cancer Res (1999) 0.83
Breast cancer and pregnancy. Semin Oncol (1989) 0.83
A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer (1993) 0.82
Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol (1999) 0.81
Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am (1999) 0.81
Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. J Natl Cancer Inst (1989) 0.81
Phase II trial of etoposide in advanced prostate cancer. Cancer Treat Rep (1984) 0.79
Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol (1992) 0.79
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer. Am J Clin Oncol (1991) 0.79
Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol (1997) 0.79
In vitro induction of human skin ornithine decarboxylase by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. J Natl Cancer Inst (1985) 0.79
Palliative communications: addressing chemotherapy in patients with advanced cancer. Ann Oncol (2012) 0.79
An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology (1997) 0.78
A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma. Am J Clin Oncol (1993) 0.78
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy. Cancer (1994) 0.78
Coumarin-induced hepatotoxicity. J Clin Oncol (1997) 0.78
Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary. Gynecol Oncol (1984) 0.78
Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer. Hosp J (1993) 0.78
Should cancer patients with incurable disease receive parenteral or enteral nutritional support? Eur J Cancer (1998) 0.77
Inhibition of phorbol ester--induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies. J Clin Oncol (1985) 0.77
A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma. Cancer (1988) 0.77
Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer (2001) 0.77
Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study. J Pain Symptom Manage (1996) 0.76
Chemotherapy-induced insulin-dependent diabetes mellitus. J Clin Oncol (1997) 0.76
Is ATP (adenosine 5'-triphosphate), like STP, a performance-enhancing additive for the tanks of cancer patients? J Natl Cancer Inst (2000) 0.76
Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma. Cancer (1997) 0.76
Estrogen deficiency: In search of symptom control and sexuality. J Natl Cancer Inst (2000) 0.76
North Central Cancer Treatment Group (NCCTG). J Natl Cancer Inst Monogr (1996) 0.76
Current management of cancer-associated anorexia and weight loss. Oncology (Williston Park) (2001) 0.76
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance). Osteoporos Int (2015) 0.75
Basophilic-eosinophilic meningitis in an undifferentiated myeloproliferative disorder. JAMA (1983) 0.75
Allopurinol mouthwash as prophylactic therapy for 5-fluorouracil-induced mucositis. Eur J Surg Oncol (1989) 0.75
The art and science of prognosis in patients with advanced cancer. Eur J Cancer (2000) 0.75
Cessation of follow-up tests with limited utility: a patient's perspective. J Clin Oncol (1996) 0.75
Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancer. J Pain Symptom Manage (1997) 0.75
Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy. Am J Clin Oncol (1988) 0.75
Prostatic cancer. South Med J (1982) 0.75
Breast cancer. Cancer Chemother Biol Response Modif (1992) 0.75
Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer. J Pain Symptom Manage (1994) 0.75
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole). Cancer Res (1990) 0.75
Snake antivenin administration in a patient allergic to horse serum. South Med J (1983) 0.75
Mitomycin C-induced pulmonary and renal toxicities. Wis Med J (1984) 0.75
Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity. Carcinogenesis (1985) 0.75
Breast cancer. Cancer Chemother Biol Response Modif (1990) 0.75
A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinoma. Cancer (1996) 0.75
Breast cancer. Cancer Chemother Biol Response Modif (1987) 0.75
Inhibition of ornithine decarboxylase activity by small doses of alpha-difluoromethylornithine. Cancer Lett (1985) 0.75
Symptom control studies: an important part of cancer control research. J Natl Cancer Inst (1991) 0.75
Breast cancer. Cancer Chemother Biol Response Modif (1988) 0.75
A new addition to the Journal of Clinical Oncology: the art of oncology--when the tumor is not the target. J Clin Oncol (2000) 0.75
Carcinoembryonic antigen. A routine test in patients with breast carcinoma? Arch Intern Med (1986) 0.75
Breast cancer. Cancer Chemother Biol Response Modif (1991) 0.75
Effects of local anesthetics on phorbol ester-induced ornithine decarboxylase activity in mouse and human skin. Anticancer Res (1985) 0.75
Prognostic factors in metastatic carcinoma of unknown primary. J Clin Oncol (1987) 0.75
Cancer anorexia/cachexia. Cancer Treat Res (1999) 0.75
Progressive linear lichen planus and metastatic carcinoma. Br J Dermatol (2005) 0.75